SlideShare a Scribd company logo
1 of 34
Cost-benefit Analysis
1
Abdur Razzaque Sarker
MHE (Health Economics), MSS (Economics)
Health Economics and Financing Research, icddrb
and
PhD Fellow in Strathclyde University, UK
Email: razzaque.sarker@gmail.com
What is Cost-Benefit Analysis
Cost Benefit Analysis (CBA) is an economic
evaluation
technique that both costs and consequences
(benefits)
are measured in monetary unit.
Net benefit = Benefits - Costs
2
 An intervention should be undertaken
if the benefits exceed the costs.
Choose the intervention with the highest net
benefit if only one intervention can be
funded
3
Why using CBA
 Resources are limited
 The intervention program should be
economically viable
 CBA adopts a broad societal
perspective as it includes all costs and
all benefits
4
Economic evaluation methods at a glance
5
Measuring cost of intervention
The cost of intervention will be
calculated
in the same way as other economic
evaluation methods (Please see ‘cost
analysis’).
6
Measuring benefits
The ways to measure monetary value of
benefits from intervention
1. Cost of illness averted
2. Contingent valuation method
(willingness to pay)
7
1. Cost-of-illness averted
The cost of illness (COI) is defined as the
value
of the resources that are expended or
foregone
as a result of a health problem (like,
diseases).
8
Perspectives of COI
Patient’s or household’s perspective
Provider’s perspective
Societal perspective
9
Costs can be classified into
three types
 Direct Costs: Direct costs related to treating the
patients (example, doctor’s visit, drugs, transport)
 Indirect Cost: Loss of productivity of patients
and care-givers
 Intangible cost: Pain, anxiety, discomfort
10
Information needs to be collected
Direct cost
 How much patients spend for medicine.
 How much money was spent for transportation
for each visit.
 Did you spend any night away from home
regarding treatment and spend money to buy
food and lodging?
 Did you spend any money for any diagnostic
tests?
 Did you pay consultation fee to the provider?
11
Indirect cost
Examples:
 At the time you got sick with cholera, were you employed?
 How much time you waited before receiving this service?
 What was your daily wage?
 How many days had you been absent from work due to illness?
 Did anybody take care of you during your illness?
 How many days she/he had been absent from work for giving you
care?
 What was her/his daily wage?
 more……
12
Information needs to be collected
Intangible cost
Difficult to measure and often a limitation of the study
13
Information needs to be collected
Provider’s actual cost of illness
Provider actual cost of illness will be calculated as
the provider’s cost for treatment excluding any fees
received from the patients for hospitalization, drug,
diagnostic tests etc.
If government implements vaccination against
cholera. The cholera hospitals (wards) can be
benefited by reducing their cost for treating cholera
patients.
14
It includes cost of providers, cost of patients or
households and costs of insurance company (if
applicable)
15
Cost of illness of society
The cost of illness that can be averted,
i.e.
benefits of the intervention will then be
adjusted for time differentials using
discount rate.
16
17
Costs Parameters Average cost Standard deviation %of total cost
Direct Medical Diagnostic 9.6 (0.1) 75.7 (1) 9
Medicine 148.7 (2) 246 (3.)
Registration fee 26.1 (0.3) 130.6 (1.7)
Paramedics home visit fee 2.8 (−) 21.5 (0.3)
Bed/ Cabin charge 16.9 (0.2) 130.7 (1.7)
Direct Non-
Medical
Transportation cost 140 (1.9) 122 (1.6) 15.6
food items 63(0.8) 85 (1.1)
Informal payment 0.7 (−) 9 (0.1)
Caregivers payment 0.1 (−) 1 (−)
Materials (mug/glass/coil etc) 10.6(0.1) 17 (0.2)
Lodging 28 (0.4) 101 (1.3)
Caregivers expenditure 113.2 (1.5) 172 (2.3)
Total direct cost 559.5 (7.4) 641.7 (8.5) 24.6
In-direct Patients income loss 811 (11) 4,301 (57)
Caregivers income loss 908 (12.2) 3,701 (49)
Total indirect cost 1,719 (23) 5,656 (75.4) 75.4
Total cost of illness of household 2,278.5 (30.4) 5,668 (75.6) 100
Average household cost for cholera treatment
18
Suppose in Mirpur area, every year 1200 patients are
affected by Cholera diseases and it is estimated by
our hospital record. A Cost of illness study
conducted and estimate the average cost for treating
cholera is $40 from societal perspective. We want to
minimized the burden of cholera diseases and he
initiated the following three intervention
A Only Vaccination
B Vaccination & hand washing technique
C Vaccine, hand washing & Water treatment
procedure
19
Intervention Total cost (C)
Outcome
(No of case averted)
A (Vaccine) 10000 200
B ( Vaccine & hand washing) 15000 650
C (Vaccine, hand washing and
water treatment) 18000 900
We want to know which intervention is
sustainable based on cost benefit analysis?
20
Decision tools:
 Net Social Benefit (NSB) = B-C
 If B > C we take the intervention, i.e. B-C
>0, we accepted that program
 If B< C i.e. B-C <0, we must rejected that
intervention
 If B = C , i.e. B-C =0, we are indifferent i.e.
it may be accepted or rejected
21
Intervention Total cost (C)
Outcome
(No of case averted)
A (Vaccine) 10000 200
B ( Vaccine & hand washing) 15000 650
C (Vaccine, hand washing and
water treatment) 18000 900
Intervention
Total cost
(C)
Outcome
(No of case averted)
Total Benefit
(B)
A (Vaccine) 10000 200 8,000
B ( Vaccine & hand washing) 15000 650 26,000
C (Vaccine, hand washing &
Water treatment) 18000 900 36,000
Since average COI is $40 for societal perspective
22
Intervention
Total cost
(C)
Outcome
(No of case
averted)
Total
Benefit (B)
Net Social
Benefit
(NSB = B-C )
A (Vaccine) 10000 500 8,000 -2,000
B ( Vaccine &
handwashing) 15000 650 26,000 11000
C (Vaccine, hand washing
& Water treatment) 18000 900 36,000 18000
 If we consider intervention A , here, B – C < 0, Rejected A
 In intervention B, here, B –C > 0, ie. NSB >0. Accepted B
In intervention C, here, B – C > 0, i,e. NSB >0. Accepted c
If we compare all that program, only one intervention can be
funded than alternative C is better, causes it gives higher net
social benefit.
23
Assigning Money Values in health
outcomes
 Human Capital Approaches
Cost of illness
 Contingent valuation method (CVM)
Willingness-to- Pay (WTP) Method
Willingness –to- Accept (WTP) Method
 CVM is a direct method which involves asking a
sample of the relevant population question about
their willingness to pay (WTP) for a certain product
(health intervention program)
 Willingness to pay (WTP) is the maximum amount
a
person would be willing to pay, sacrifice or
exchange in
order to receive a good or to avoid risk
 If individuals answer truthfully, their answers will
24
2. Contingent valuation method
(CVM)
CV question can be divided into open-
ended and discrete choice.
Open-ended
Using bidding game technique respondents
are asked to state their maximum WTP for
the benefit of a specific intervention.
25
26
To introduce the cholera vaccine we asked
to all household head to know what they
willing to pay (max. WTP) to avoidable this
loss (COI).
 Did you agree to pay for two doses cholera
vaccine
Yes…..(1)
No….(2)
 How much you want to pay for two doses
oral Cholera vaccine ?
BDT……………………
27
 In bidding game (like an auction),
respondents are offered with a bid for
acceptance or rejection. Depending on
respondent’s answer, the bid is then lowered or
increased until respondent’s maximum WTP is
reached.
 We bid a price to household head and know
about his WTP which may be increasing or
decreasing. And finally we select final WTP.
Discrete
Respondents are offered a bid and asked for
either accepting or rejecting. Using different
bids in different sub-samples, it is possible to
calculate the percentage of respondents who
are willing to pay as a function of price (bid).
28
29
 Did you agree to pay for two doses
cholera vaccine
Yes…..(1)
No….(2)
 If Yes, then which price …
3*2 = 6 USD per family member….....(1)
4*2 = 8 USD per family member…….(2)
4.5*2= 9 USD per family member…….(3)
5*2 =10 USD per family member…….(4)
5.5*2 =11 USD per family member…….(5)
Survey for contingent valuation
Creating a survey instrument for capturing
individuals' WTP
(a) designing the hypothetical scenario;
(b) creating a scenario about the means of
payment
Use the survey instrument with a sample of
the population of interest
30
31
Where,
i= indexes respondents
Y= Income
E= Education
A = Age
D=disease or health risk exposure experience
WTPi =
f
(
Yi, Ei, Ai, Di, ... )
Total WTP is achieved by deriving the
population average WTP from the data and
multiplying it by the population size, N.
32
Note to interviewer:
Describe the cholera vaccine, dose and effectiveness both for adult and child to the respondents following
the structured description of the product.
Would you be willing to pay X Taka for full vaccination
for you?
Yes
No
If yes, please explain your reasons for agreeing to pay? 1. The amount is affordable
2. I don’t want to suffer from cholera
Other, specify ___________
If no, pls explain your reasons for not wanting to pay? 1. Too expensive
2. Unable to pay
Other, specify ____________
Would you be willing to pay XX Taka for full vaccination
for other members of your family?
Yes
No
If yes, please explain your reasons for agreeing to pay? 1. The amount is affordable
2. I don’t want to suffer from cholera
Other, specify ___________
If no, pls explain your reasons for not wanting to pay? 1. Too expensive
2. Unable to pay
Other, specify ____________
What would be the maximum amount you would be
willing to pay for yourself?
______________________ Tk
What would be the maximum amount you would be
willing to pay for other family members?
______________________ Tk
Total benefit of the proposed intervention can be calculated by
multiplying average WTP with total number of population in
interest group.
Benefits of the intervention (WTP) will then be adjusted for time
differentials using discount rate.
Example,
Total WTP = 10,000 Taka (after discounting)
Total cost of intervention = 8,000 Taka (after discounting)
Net benefit = 10,000 – 8,000 Taka = 2,000 Taka
Conclusion: If net benefit is higher than zero, then intervention
program is acceptable
33
THANKS
34
Email: razzaque.sarker@gmail.com

More Related Content

What's hot

Cost utility analysis
Cost utility analysisCost utility analysis
Cost utility analysisARUNAYESUDAS
 
Cost Benefit Analysis in Health Care
Cost Benefit Analysis in Health CareCost Benefit Analysis in Health Care
Cost Benefit Analysis in Health CarePrabesh Ghimire
 
Pharmacoeconomics by harsh
Pharmacoeconomics by harshPharmacoeconomics by harsh
Pharmacoeconomics by harshHarsh Yadav
 
Economic evaluations health economics presentation
Economic evaluations   health economics presentationEconomic evaluations   health economics presentation
Economic evaluations health economics presentationAhmed Zaahir
 
Cost Utility Analysis
Cost Utility AnalysisCost Utility Analysis
Cost Utility AnalysisLanceCatedral
 
Healthcare Economic evaluation
Healthcare Economic evaluationHealthcare Economic evaluation
Healthcare Economic evaluationBPKIHS
 
Introduction to budget impact analysis
Introduction to budget impact analysisIntroduction to budget impact analysis
Introduction to budget impact analysisNazmiLianaAzmi
 
Quality adjusted life years(QALYs).pptx
Quality adjusted life years(QALYs).pptxQuality adjusted life years(QALYs).pptx
Quality adjusted life years(QALYs).pptxRanjanaKoirala1
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics academic
 
Cost Minimization Analysis in Health Care
Cost Minimization Analysis in Health CareCost Minimization Analysis in Health Care
Cost Minimization Analysis in Health CarePrabesh Ghimire
 
Cost Effectiveness Analysis in Health economics
Cost Effectiveness Analysis in Health economicsCost Effectiveness Analysis in Health economics
Cost Effectiveness Analysis in Health economicsGerardo García
 
DALYs and QALYs by samrat gurung
DALYs and QALYs by samrat gurungDALYs and QALYs by samrat gurung
DALYs and QALYs by samrat gurungSamrat Gurung
 
Concept of Economic Evaluation in Health Care
Concept of Economic Evaluation in Health CareConcept of Economic Evaluation in Health Care
Concept of Economic Evaluation in Health CarePrabesh Ghimire
 

What's hot (20)

Cost concept and economic evaluation
Cost concept and economic evaluationCost concept and economic evaluation
Cost concept and economic evaluation
 
Cost utility analysis
Cost utility analysisCost utility analysis
Cost utility analysis
 
Cost Benefit Analysis in Health Care
Cost Benefit Analysis in Health CareCost Benefit Analysis in Health Care
Cost Benefit Analysis in Health Care
 
Discounting in Health Economic Evaluation!
Discounting in Health Economic Evaluation!Discounting in Health Economic Evaluation!
Discounting in Health Economic Evaluation!
 
Pharmacoeconomics by harsh
Pharmacoeconomics by harshPharmacoeconomics by harsh
Pharmacoeconomics by harsh
 
Economic evaluations health economics presentation
Economic evaluations   health economics presentationEconomic evaluations   health economics presentation
Economic evaluations health economics presentation
 
Cost Utility Analysis
Cost Utility AnalysisCost Utility Analysis
Cost Utility Analysis
 
Cost effectiveness analysis
Cost effectiveness analysisCost effectiveness analysis
Cost effectiveness analysis
 
Healthcare Economic evaluation
Healthcare Economic evaluationHealthcare Economic evaluation
Healthcare Economic evaluation
 
Introduction to budget impact analysis
Introduction to budget impact analysisIntroduction to budget impact analysis
Introduction to budget impact analysis
 
Quality adjusted life years(QALYs).pptx
Quality adjusted life years(QALYs).pptxQuality adjusted life years(QALYs).pptx
Quality adjusted life years(QALYs).pptx
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Cost Minimization Analysis in Health Care
Cost Minimization Analysis in Health CareCost Minimization Analysis in Health Care
Cost Minimization Analysis in Health Care
 
Cost Effectiveness Analysis in Health economics
Cost Effectiveness Analysis in Health economicsCost Effectiveness Analysis in Health economics
Cost Effectiveness Analysis in Health economics
 
DALYs and QALYs by samrat gurung
DALYs and QALYs by samrat gurungDALYs and QALYs by samrat gurung
DALYs and QALYs by samrat gurung
 
Concept of Economic Evaluation in Health Care
Concept of Economic Evaluation in Health CareConcept of Economic Evaluation in Health Care
Concept of Economic Evaluation in Health Care
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
 
Health economics
Health economicsHealth economics
Health economics
 

Viewers also liked

"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ..."Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...Vall d'Hebron Institute of Research (VHIR)
 
Cost Benifit Analysis
Cost Benifit AnalysisCost Benifit Analysis
Cost Benifit AnalysisTareq Zarouni
 
Benifit cost analysis
Benifit cost analysisBenifit cost analysis
Benifit cost analysisjnujaipur
 
Cost-benefit analysis
Cost-benefit analysisCost-benefit analysis
Cost-benefit analysisSoniya Balan
 
Cost-Benefit Analysis
Cost-Benefit AnalysisCost-Benefit Analysis
Cost-Benefit AnalysisSakshi Sharma
 
Fundamental Diseases: Why We Should Care About The Rare
Fundamental Diseases: Why We Should Care About The RareFundamental Diseases: Why We Should Care About The Rare
Fundamental Diseases: Why We Should Care About The RareFindacure
 
Similarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare DiseasesSimilarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare Diseasesjangeissler
 
Genomics: Shifting the Paradigm for Rare Diseases
Genomics: Shifting the Paradigm for Rare DiseasesGenomics: Shifting the Paradigm for Rare Diseases
Genomics: Shifting the Paradigm for Rare DiseasesHannes Smárason
 
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...Canadian Organization for Rare Disorders
 
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...Canadian Organization for Rare Disorders
 
Vibrio cholerae
Vibrio choleraeVibrio cholerae
Vibrio choleraecamiij1
 
Investment Analysis Project Presentation
Investment Analysis  Project PresentationInvestment Analysis  Project Presentation
Investment Analysis Project Presentationnroopraj24
 
Risk analysis and management
Risk analysis and managementRisk analysis and management
Risk analysis and managementgnitu
 

Viewers also liked (20)

"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ..."Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
 
Cost Benifit Analysis
Cost Benifit AnalysisCost Benifit Analysis
Cost Benifit Analysis
 
Benifit cost analysis
Benifit cost analysisBenifit cost analysis
Benifit cost analysis
 
Cost-benefit analysis
Cost-benefit analysisCost-benefit analysis
Cost-benefit analysis
 
Cost-Benefit Analysis
Cost-Benefit AnalysisCost-Benefit Analysis
Cost-Benefit Analysis
 
Health economics
Health economicsHealth economics
Health economics
 
Session 13 francesc_palau
Session 13 francesc_palauSession 13 francesc_palau
Session 13 francesc_palau
 
Rare diseases
Rare diseasesRare diseases
Rare diseases
 
Nbs manual 28-6-2015
Nbs manual 28-6-2015 Nbs manual 28-6-2015
Nbs manual 28-6-2015
 
Fundamental Diseases: Why We Should Care About The Rare
Fundamental Diseases: Why We Should Care About The RareFundamental Diseases: Why We Should Care About The Rare
Fundamental Diseases: Why We Should Care About The Rare
 
Similarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare DiseasesSimilarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare Diseases
 
Cluj
ClujCluj
Cluj
 
Newborn screening kuwait
Newborn screening kuwaitNewborn screening kuwait
Newborn screening kuwait
 
Genomics: Shifting the Paradigm for Rare Diseases
Genomics: Shifting the Paradigm for Rare DiseasesGenomics: Shifting the Paradigm for Rare Diseases
Genomics: Shifting the Paradigm for Rare Diseases
 
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
 
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
 
Vibrio cholerae
Vibrio choleraeVibrio cholerae
Vibrio cholerae
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Investment Analysis Project Presentation
Investment Analysis  Project PresentationInvestment Analysis  Project Presentation
Investment Analysis Project Presentation
 
Risk analysis and management
Risk analysis and managementRisk analysis and management
Risk analysis and management
 

Similar to Cost benifit analysis

Seminar on health economic copy
Seminar on health economic   copySeminar on health economic   copy
Seminar on health economic copyPreeti Rai
 
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014GlobalResearchUCSF
 
1 gf h econ slides basics
1 gf h econ slides basics1 gf h econ slides basics
1 gf h econ slides basicsGreg Fell
 
lect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.pptlect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.pptDhanang Nugraha
 
Using financial incentives to increase testing uptake versie 2
Using financial incentives to increase testing uptake versie 2Using financial incentives to increase testing uptake versie 2
Using financial incentives to increase testing uptake versie 2Jennie van de Weerd
 
Health Technology Assessment- Overview
Health Technology Assessment- OverviewHealth Technology Assessment- Overview
Health Technology Assessment- Overviewshashi sinha
 
HCA 205 Week 2 Quiz Assiignment 3.docx
HCA 205 Week 2 Quiz Assiignment 3.docxHCA 205 Week 2 Quiz Assiignment 3.docx
HCA 205 Week 2 Quiz Assiignment 3.docxsdfghj21
 
Health economics
Health economicsHealth economics
Health economicsdipesh125
 
Nguyễn Duy Anh - Báo cáo oral.pdf
Nguyễn Duy Anh - Báo cáo oral.pdfNguyễn Duy Anh - Báo cáo oral.pdf
Nguyễn Duy Anh - Báo cáo oral.pdfSon Nguyen
 
Assignment Exercise 4–1 Contractual Allowances Physician office.docx
Assignment Exercise 4–1 Contractual Allowances Physician office.docxAssignment Exercise 4–1 Contractual Allowances Physician office.docx
Assignment Exercise 4–1 Contractual Allowances Physician office.docxrock73
 
2 tool to estimate patient costs literature review_final
2 tool to estimate patient costs literature review_final2 tool to estimate patient costs literature review_final
2 tool to estimate patient costs literature review_finalAira Bhabe
 
Wound care in the Physical Therapy Private Practice Outpatient Sector: A busi...
Wound care in the Physical Therapy Private Practice Outpatient Sector: A busi...Wound care in the Physical Therapy Private Practice Outpatient Sector: A busi...
Wound care in the Physical Therapy Private Practice Outpatient Sector: A busi...Michelle Stauffer
 
Rural Urgent Care Centers Business PlanI. Executive Summar.docx
Rural Urgent Care Centers Business PlanI. Executive Summar.docxRural Urgent Care Centers Business PlanI. Executive Summar.docx
Rural Urgent Care Centers Business PlanI. Executive Summar.docxanhlodge
 
Pharmacoeconomics (Basics for MD Pharmacology)
Pharmacoeconomics (Basics for MD Pharmacology)Pharmacoeconomics (Basics for MD Pharmacology)
Pharmacoeconomics (Basics for MD Pharmacology)Dr. Advaitha MV
 
Healthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of DiseaseHealthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of DiseaseRevital (Tali) Hirsch
 
ISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US PerspectiveISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US PerspectiveOffice of Health Economics
 
Framework for assessing the economic costs and burdens of zoonotic disease
Framework for assessing the economic costs and burdens of zoonotic diseaseFramework for assessing the economic costs and burdens of zoonotic disease
Framework for assessing the economic costs and burdens of zoonotic diseaseILRI
 
BHA 3002, Health Care Management 1 Course Learning Ou.docx
BHA 3002, Health Care Management 1 Course Learning Ou.docxBHA 3002, Health Care Management 1 Course Learning Ou.docx
BHA 3002, Health Care Management 1 Course Learning Ou.docxtarifarmarie
 

Similar to Cost benifit analysis (20)

Seminar on health economic copy
Seminar on health economic   copySeminar on health economic   copy
Seminar on health economic copy
 
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014
Comparative Effectiveness: UCSF East Africa Global Health -Kisumu 2014
 
1 gf h econ slides basics
1 gf h econ slides basics1 gf h econ slides basics
1 gf h econ slides basics
 
lect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.pptlect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
 
Using financial incentives to increase testing uptake versie 2
Using financial incentives to increase testing uptake versie 2Using financial incentives to increase testing uptake versie 2
Using financial incentives to increase testing uptake versie 2
 
Health Technology Assessment- Overview
Health Technology Assessment- OverviewHealth Technology Assessment- Overview
Health Technology Assessment- Overview
 
HCA 205 Week 2 Quiz Assiignment 3.docx
HCA 205 Week 2 Quiz Assiignment 3.docxHCA 205 Week 2 Quiz Assiignment 3.docx
HCA 205 Week 2 Quiz Assiignment 3.docx
 
Health economics
Health economicsHealth economics
Health economics
 
Nguyễn Duy Anh - Báo cáo oral.pdf
Nguyễn Duy Anh - Báo cáo oral.pdfNguyễn Duy Anh - Báo cáo oral.pdf
Nguyễn Duy Anh - Báo cáo oral.pdf
 
Assignment Exercise 4–1 Contractual Allowances Physician office.docx
Assignment Exercise 4–1 Contractual Allowances Physician office.docxAssignment Exercise 4–1 Contractual Allowances Physician office.docx
Assignment Exercise 4–1 Contractual Allowances Physician office.docx
 
An Introduction to Health Economics
An Introduction to Health EconomicsAn Introduction to Health Economics
An Introduction to Health Economics
 
2 tool to estimate patient costs literature review_final
2 tool to estimate patient costs literature review_final2 tool to estimate patient costs literature review_final
2 tool to estimate patient costs literature review_final
 
UNIT 3 .pptx
UNIT 3 .pptxUNIT 3 .pptx
UNIT 3 .pptx
 
Wound care in the Physical Therapy Private Practice Outpatient Sector: A busi...
Wound care in the Physical Therapy Private Practice Outpatient Sector: A busi...Wound care in the Physical Therapy Private Practice Outpatient Sector: A busi...
Wound care in the Physical Therapy Private Practice Outpatient Sector: A busi...
 
Rural Urgent Care Centers Business PlanI. Executive Summar.docx
Rural Urgent Care Centers Business PlanI. Executive Summar.docxRural Urgent Care Centers Business PlanI. Executive Summar.docx
Rural Urgent Care Centers Business PlanI. Executive Summar.docx
 
Pharmacoeconomics (Basics for MD Pharmacology)
Pharmacoeconomics (Basics for MD Pharmacology)Pharmacoeconomics (Basics for MD Pharmacology)
Pharmacoeconomics (Basics for MD Pharmacology)
 
Healthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of DiseaseHealthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of Disease
 
ISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US PerspectiveISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
 
Framework for assessing the economic costs and burdens of zoonotic disease
Framework for assessing the economic costs and burdens of zoonotic diseaseFramework for assessing the economic costs and burdens of zoonotic disease
Framework for assessing the economic costs and burdens of zoonotic disease
 
BHA 3002, Health Care Management 1 Course Learning Ou.docx
BHA 3002, Health Care Management 1 Course Learning Ou.docxBHA 3002, Health Care Management 1 Course Learning Ou.docx
BHA 3002, Health Care Management 1 Course Learning Ou.docx
 

More from Abdur Razzaque Sarker, PhD (17)

Scientific Report Writing.pdf
Scientific Report Writing.pdfScientific Report Writing.pdf
Scientific Report Writing.pdf
 
Cost Analysis_ Case Study
Cost Analysis_ Case StudyCost Analysis_ Case Study
Cost Analysis_ Case Study
 
Cost analysis
Cost analysisCost analysis
Cost analysis
 
Disability Adjusted Life Years
Disability Adjusted Life YearsDisability Adjusted Life Years
Disability Adjusted Life Years
 
Tools for health economics
Tools for health economicsTools for health economics
Tools for health economics
 
Measuring health
Measuring healthMeasuring health
Measuring health
 
Health economics
Health economicsHealth economics
Health economics
 
Universal health coverage
Universal health coverageUniversal health coverage
Universal health coverage
 
Resource allocation
Resource allocationResource allocation
Resource allocation
 
Health system
Health systemHealth system
Health system
 
Health insurence
Health insurenceHealth insurence
Health insurence
 
Equity in health system
Equity in health systemEquity in health system
Equity in health system
 
Basics health economics
Basics health economicsBasics health economics
Basics health economics
 
Micro economics tools for health economics
Micro economics tools for health economicsMicro economics tools for health economics
Micro economics tools for health economics
 
Health economics an overview
Health economics an overviewHealth economics an overview
Health economics an overview
 
Burden of Disease using DALYs
Burden of Disease using DALYsBurden of Disease using DALYs
Burden of Disease using DALYs
 
Disabilty Adjusted Life Years(DALYs)
Disabilty Adjusted Life Years(DALYs)Disabilty Adjusted Life Years(DALYs)
Disabilty Adjusted Life Years(DALYs)
 

Recently uploaded

hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...
hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...
hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...delhimodelshub1
 
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012Call Girls Service Gurgaon
 
Hot Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In Chandigarh
Hot  Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In ChandigarhHot  Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In Chandigarh
Hot Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In ChandigarhVip call girls In Chandigarh
 
Call Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any TimeCall Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any Timedelhimodelshub1
 
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near MeVIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Memriyagarg453
 
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In RaipurCall Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipurgragmanisha42
 
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetChandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meetpriyashah722354
 
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...delhimodelshub1
 
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...delhimodelshub1
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...Vip call girls In Chandigarh
 
Hot Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In Ludhiana
Hot  Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In LudhianaHot  Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In Ludhiana
Hot Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In LudhianaRussian Call Girls in Ludhiana
 
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in LucknowRussian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknowgragteena
 
Russian Call Girls Hyderabad Indira 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Indira 9907093804 Independent Escort Service Hyd...Russian Call Girls Hyderabad Indira 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Indira 9907093804 Independent Escort Service Hyd...delhimodelshub1
 
Basics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptxBasics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptxAyush Gupta
 
Call Girls Hyderabad Krisha 9907093804 Independent Escort Service Hyderabad
Call Girls Hyderabad Krisha 9907093804 Independent Escort Service HyderabadCall Girls Hyderabad Krisha 9907093804 Independent Escort Service Hyderabad
Call Girls Hyderabad Krisha 9907093804 Independent Escort Service Hyderabaddelhimodelshub1
 
Leading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsLeading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsHelenBevan4
 

Recently uploaded (20)

hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...
hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...
hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...
 
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012
 
Hot Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In Chandigarh
Hot  Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In ChandigarhHot  Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In Chandigarh
Hot Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In Chandigarh
 
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service GuwahatiCall Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
 
Call Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any TimeCall Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any Time
 
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near MeVIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
 
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In RaipurCall Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
 
#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi
#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi
#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi
 
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetChandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
 
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...
 
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service LucknowCall Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
 
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
 
Hot Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In Ludhiana
Hot  Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In LudhianaHot  Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In Ludhiana
Hot Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In Ludhiana
 
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in LucknowRussian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
 
Russian Call Girls Hyderabad Indira 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Indira 9907093804 Independent Escort Service Hyd...Russian Call Girls Hyderabad Indira 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Indira 9907093804 Independent Escort Service Hyd...
 
Basics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptxBasics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptx
 
Call Girls Hyderabad Krisha 9907093804 Independent Escort Service Hyderabad
Call Girls Hyderabad Krisha 9907093804 Independent Escort Service HyderabadCall Girls Hyderabad Krisha 9907093804 Independent Escort Service Hyderabad
Call Girls Hyderabad Krisha 9907093804 Independent Escort Service Hyderabad
 
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service LucknowVIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
 
Leading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsLeading transformational change: inner and outer skills
Leading transformational change: inner and outer skills
 

Cost benifit analysis

  • 1. Cost-benefit Analysis 1 Abdur Razzaque Sarker MHE (Health Economics), MSS (Economics) Health Economics and Financing Research, icddrb and PhD Fellow in Strathclyde University, UK Email: razzaque.sarker@gmail.com
  • 2. What is Cost-Benefit Analysis Cost Benefit Analysis (CBA) is an economic evaluation technique that both costs and consequences (benefits) are measured in monetary unit. Net benefit = Benefits - Costs 2
  • 3.  An intervention should be undertaken if the benefits exceed the costs. Choose the intervention with the highest net benefit if only one intervention can be funded 3
  • 4. Why using CBA  Resources are limited  The intervention program should be economically viable  CBA adopts a broad societal perspective as it includes all costs and all benefits 4
  • 6. Measuring cost of intervention The cost of intervention will be calculated in the same way as other economic evaluation methods (Please see ‘cost analysis’). 6
  • 7. Measuring benefits The ways to measure monetary value of benefits from intervention 1. Cost of illness averted 2. Contingent valuation method (willingness to pay) 7
  • 8. 1. Cost-of-illness averted The cost of illness (COI) is defined as the value of the resources that are expended or foregone as a result of a health problem (like, diseases). 8
  • 9. Perspectives of COI Patient’s or household’s perspective Provider’s perspective Societal perspective 9
  • 10. Costs can be classified into three types  Direct Costs: Direct costs related to treating the patients (example, doctor’s visit, drugs, transport)  Indirect Cost: Loss of productivity of patients and care-givers  Intangible cost: Pain, anxiety, discomfort 10
  • 11. Information needs to be collected Direct cost  How much patients spend for medicine.  How much money was spent for transportation for each visit.  Did you spend any night away from home regarding treatment and spend money to buy food and lodging?  Did you spend any money for any diagnostic tests?  Did you pay consultation fee to the provider? 11
  • 12. Indirect cost Examples:  At the time you got sick with cholera, were you employed?  How much time you waited before receiving this service?  What was your daily wage?  How many days had you been absent from work due to illness?  Did anybody take care of you during your illness?  How many days she/he had been absent from work for giving you care?  What was her/his daily wage?  more…… 12 Information needs to be collected
  • 13. Intangible cost Difficult to measure and often a limitation of the study 13 Information needs to be collected
  • 14. Provider’s actual cost of illness Provider actual cost of illness will be calculated as the provider’s cost for treatment excluding any fees received from the patients for hospitalization, drug, diagnostic tests etc. If government implements vaccination against cholera. The cholera hospitals (wards) can be benefited by reducing their cost for treating cholera patients. 14
  • 15. It includes cost of providers, cost of patients or households and costs of insurance company (if applicable) 15 Cost of illness of society
  • 16. The cost of illness that can be averted, i.e. benefits of the intervention will then be adjusted for time differentials using discount rate. 16
  • 17. 17 Costs Parameters Average cost Standard deviation %of total cost Direct Medical Diagnostic 9.6 (0.1) 75.7 (1) 9 Medicine 148.7 (2) 246 (3.) Registration fee 26.1 (0.3) 130.6 (1.7) Paramedics home visit fee 2.8 (−) 21.5 (0.3) Bed/ Cabin charge 16.9 (0.2) 130.7 (1.7) Direct Non- Medical Transportation cost 140 (1.9) 122 (1.6) 15.6 food items 63(0.8) 85 (1.1) Informal payment 0.7 (−) 9 (0.1) Caregivers payment 0.1 (−) 1 (−) Materials (mug/glass/coil etc) 10.6(0.1) 17 (0.2) Lodging 28 (0.4) 101 (1.3) Caregivers expenditure 113.2 (1.5) 172 (2.3) Total direct cost 559.5 (7.4) 641.7 (8.5) 24.6 In-direct Patients income loss 811 (11) 4,301 (57) Caregivers income loss 908 (12.2) 3,701 (49) Total indirect cost 1,719 (23) 5,656 (75.4) 75.4 Total cost of illness of household 2,278.5 (30.4) 5,668 (75.6) 100 Average household cost for cholera treatment
  • 18. 18 Suppose in Mirpur area, every year 1200 patients are affected by Cholera diseases and it is estimated by our hospital record. A Cost of illness study conducted and estimate the average cost for treating cholera is $40 from societal perspective. We want to minimized the burden of cholera diseases and he initiated the following three intervention A Only Vaccination B Vaccination & hand washing technique C Vaccine, hand washing & Water treatment procedure
  • 19. 19 Intervention Total cost (C) Outcome (No of case averted) A (Vaccine) 10000 200 B ( Vaccine & hand washing) 15000 650 C (Vaccine, hand washing and water treatment) 18000 900 We want to know which intervention is sustainable based on cost benefit analysis?
  • 20. 20 Decision tools:  Net Social Benefit (NSB) = B-C  If B > C we take the intervention, i.e. B-C >0, we accepted that program  If B< C i.e. B-C <0, we must rejected that intervention  If B = C , i.e. B-C =0, we are indifferent i.e. it may be accepted or rejected
  • 21. 21 Intervention Total cost (C) Outcome (No of case averted) A (Vaccine) 10000 200 B ( Vaccine & hand washing) 15000 650 C (Vaccine, hand washing and water treatment) 18000 900 Intervention Total cost (C) Outcome (No of case averted) Total Benefit (B) A (Vaccine) 10000 200 8,000 B ( Vaccine & hand washing) 15000 650 26,000 C (Vaccine, hand washing & Water treatment) 18000 900 36,000 Since average COI is $40 for societal perspective
  • 22. 22 Intervention Total cost (C) Outcome (No of case averted) Total Benefit (B) Net Social Benefit (NSB = B-C ) A (Vaccine) 10000 500 8,000 -2,000 B ( Vaccine & handwashing) 15000 650 26,000 11000 C (Vaccine, hand washing & Water treatment) 18000 900 36,000 18000  If we consider intervention A , here, B – C < 0, Rejected A  In intervention B, here, B –C > 0, ie. NSB >0. Accepted B In intervention C, here, B – C > 0, i,e. NSB >0. Accepted c If we compare all that program, only one intervention can be funded than alternative C is better, causes it gives higher net social benefit.
  • 23. 23 Assigning Money Values in health outcomes  Human Capital Approaches Cost of illness  Contingent valuation method (CVM) Willingness-to- Pay (WTP) Method Willingness –to- Accept (WTP) Method
  • 24.  CVM is a direct method which involves asking a sample of the relevant population question about their willingness to pay (WTP) for a certain product (health intervention program)  Willingness to pay (WTP) is the maximum amount a person would be willing to pay, sacrifice or exchange in order to receive a good or to avoid risk  If individuals answer truthfully, their answers will 24 2. Contingent valuation method (CVM)
  • 25. CV question can be divided into open- ended and discrete choice. Open-ended Using bidding game technique respondents are asked to state their maximum WTP for the benefit of a specific intervention. 25
  • 26. 26 To introduce the cholera vaccine we asked to all household head to know what they willing to pay (max. WTP) to avoidable this loss (COI).  Did you agree to pay for two doses cholera vaccine Yes…..(1) No….(2)  How much you want to pay for two doses oral Cholera vaccine ? BDT……………………
  • 27. 27  In bidding game (like an auction), respondents are offered with a bid for acceptance or rejection. Depending on respondent’s answer, the bid is then lowered or increased until respondent’s maximum WTP is reached.  We bid a price to household head and know about his WTP which may be increasing or decreasing. And finally we select final WTP.
  • 28. Discrete Respondents are offered a bid and asked for either accepting or rejecting. Using different bids in different sub-samples, it is possible to calculate the percentage of respondents who are willing to pay as a function of price (bid). 28
  • 29. 29  Did you agree to pay for two doses cholera vaccine Yes…..(1) No….(2)  If Yes, then which price … 3*2 = 6 USD per family member….....(1) 4*2 = 8 USD per family member…….(2) 4.5*2= 9 USD per family member…….(3) 5*2 =10 USD per family member…….(4) 5.5*2 =11 USD per family member…….(5)
  • 30. Survey for contingent valuation Creating a survey instrument for capturing individuals' WTP (a) designing the hypothetical scenario; (b) creating a scenario about the means of payment Use the survey instrument with a sample of the population of interest 30
  • 31. 31 Where, i= indexes respondents Y= Income E= Education A = Age D=disease or health risk exposure experience WTPi = f ( Yi, Ei, Ai, Di, ... ) Total WTP is achieved by deriving the population average WTP from the data and multiplying it by the population size, N.
  • 32. 32 Note to interviewer: Describe the cholera vaccine, dose and effectiveness both for adult and child to the respondents following the structured description of the product. Would you be willing to pay X Taka for full vaccination for you? Yes No If yes, please explain your reasons for agreeing to pay? 1. The amount is affordable 2. I don’t want to suffer from cholera Other, specify ___________ If no, pls explain your reasons for not wanting to pay? 1. Too expensive 2. Unable to pay Other, specify ____________ Would you be willing to pay XX Taka for full vaccination for other members of your family? Yes No If yes, please explain your reasons for agreeing to pay? 1. The amount is affordable 2. I don’t want to suffer from cholera Other, specify ___________ If no, pls explain your reasons for not wanting to pay? 1. Too expensive 2. Unable to pay Other, specify ____________ What would be the maximum amount you would be willing to pay for yourself? ______________________ Tk What would be the maximum amount you would be willing to pay for other family members? ______________________ Tk
  • 33. Total benefit of the proposed intervention can be calculated by multiplying average WTP with total number of population in interest group. Benefits of the intervention (WTP) will then be adjusted for time differentials using discount rate. Example, Total WTP = 10,000 Taka (after discounting) Total cost of intervention = 8,000 Taka (after discounting) Net benefit = 10,000 – 8,000 Taka = 2,000 Taka Conclusion: If net benefit is higher than zero, then intervention program is acceptable 33